Cibus (CBUS) Return on Assets (2017 - 2026)

Cibus (CBUS) posted Return on Assets of 0.0% for Q4 2025, down 11.67% sequentially from 0.0% in Q3 2025, and little changed YoY from 0.0% in Q4 2024.

Cibus (CBUS) Return on Assets (2017 - 2026) Analysis & Trends

Cibus has reported Return on Assets for 9 years, with the latest figure at 0.0% in Q4 2025.

Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets slipped to 0.0% in Q4 2025 per CBUS's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q3 2023 and troughed at 0.01% in Q3 2024.
A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
The sharpest annual moves came in 2023 and 2024: Return on Assets rose 1 bps in 2023, then decreased 1 bps in 2024.
Over 5 years, Return on Assets stood at 0.01% in 2021, then advanced by 10 bps to 0.01% in 2022, then gained by 27 bps to 0.01% in 2023, then tumbled by 56 bps to 0.01% in 2024, then jumped by 47 bps to 0.0% in 2025.
According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.00%
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	0.00%
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	0.00%
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	0.00%
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	0.00%
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.00%
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	0.00%
10	Cibus	131.25 Mn	110.82 Mn	-	0.00%

Download Data